Ignite Creation Date:
2025-12-25 @ 1:43 AM
Ignite Modification Date:
2026-02-20 @ 4:46 PM
Study NCT ID:
NCT01871194
Status:
COMPLETED
Last Update Posted:
2018-01-30
First Post:
2013-05-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Observational Post-Authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of Rivaroxaban (Xarelto®).
Sponsor:
Professor Saad Shakir
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-05
Start Date Type:
None
Primary Completion Date:
2016-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-09
Completion Date Type:
ACTUAL
First Submit Date:
2013-05-29
First Submit QC Date:
None
Study First Post Date:
2013-06-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-26
Last Update Post Date:
2018-01-30
Last Update Post Date Type:
ACTUAL